These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 25392115)

  • 21. Differential effects of food on the bioavailability of controlled-release oxycodone tablets and immediate-release oxycodone solution.
    Benziger DP; Kaiko RF; Miotto JB; Fitzmartin RD; Reder RF; Chasin M
    J Pharm Sci; 1996 Apr; 85(4):407-10. PubMed ID: 8901078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relative Oral Bioavailability of an Abuse-Deterrent, Immediate-Release Formulation of Oxycodone, Oxycodone ARIR in a Randomized Study.
    Webster LR; Kinzler ER; Pantaleon C; Iverson M; Aigner S
    Adv Ther; 2019 Jul; 36(7):1730-1740. PubMed ID: 31065992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The pharmacokinetics of oxycodone.
    Lugo RA; Kern SE
    J Pain Palliat Care Pharmacother; 2004; 18(4):17-30. PubMed ID: 15760805
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination oxycodone 5 mg/ibuprofen 400 mg for the treatment of pain after abdominal or pelvic surgery in women: a randomized, double-blind, placebo- and active-controlled parallel-group study.
    Singla N; Pong A; Newman K;
    Clin Ther; 2005 Jan; 27(1):45-57. PubMed ID: 15763605
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CYP2D6 pharmacogenetic and oxycodone pharmacokinetic association study in pediatric surgical patients.
    Balyan R; Mecoli M; Venkatasubramanian R; Chidambaran V; Kamos N; Clay S; Moore DL; Mavi J; Glover CD; Szmuk P; Vinks A; Sadhasivam S
    Pharmacogenomics; 2017 Mar; 18(4):337-348. PubMed ID: 28244808
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A single-dose, 3-way crossover pharmacokinetic comparison between immediate-release oxycodone hydrochloride with aversion technology (IRO-A, Oxecta), IRO-a with Niacin, and Oxycodone Hydrochloride (Roxicodone) in healthy adults under fasting conditions.
    Leibowitz MT; Zamora CA; Brzeczko AW; Stark JG
    Am J Ther; 2014; 21(2):99-105. PubMed ID: 22357166
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics and Bioequivalence Evaluation of a New Oxycodone Tamper-Resistant Tablet Administered with an Opioid Antagonist in Patients with Chronic Pain.
    Luo Z; Miao J; Shu S; Wang Y; Zhu X; Hu C; Shen Y
    Clin Drug Investig; 2020 Feb; 40(2):139-148. PubMed ID: 31679120
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized, double-blind, placebo-controlled study of the abuse potential of different formulations of oral oxycodone.
    Webster LR; Bath B; Medve RA; Marmon T; Stoddard GJ
    Pain Med; 2012 Jun; 13(6):790-801. PubMed ID: 22568663
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical efficacy of controlled-release oxycodone 20 mg administered on a 12-h dosing schedule on the management of postoperative pain after breast surgery for cancer.
    Kampe S; Warm M; Kaufmann J; Hundegger S; Mellinghoff H; Kiencke P
    Curr Med Res Opin; 2004; 20(2):199-202. PubMed ID: 15006014
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Grapefruit juice enhances the exposure to oral oxycodone.
    Nieminen TH; Hagelberg NM; Saari TI; Neuvonen M; Neuvonen PJ; Laine K; Olkkola KT
    Basic Clin Pharmacol Toxicol; 2010 Oct; 107(4):782-8. PubMed ID: 20406214
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Roux-en-Y gastric bypass on the pharmacokinetic-pharmacodynamic relationships of liquid and controlled-release formulations of oxycodone.
    Ladebo L; Abuhelwa AY; Foster DJR; Kroustrup JP; Pacyk GJ; Kongstad KT; Drewes AM; Christrup LL; Olesen AE
    Basic Clin Pharmacol Toxicol; 2021 Sep; 129(3):232-245. PubMed ID: 34228875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Population pharmacokinetics and analgesic potency of oxycodone.
    Choi BM; Lee YH; An SM; Lee SH; Lee EK; Noh GJ
    Br J Clin Pharmacol; 2017 Feb; 83(2):314-325. PubMed ID: 27558774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the pharmacokinetics of paracetamol from two generic products in patients after total gastric resection.
    Szałek E; Kamińska A; Murawa D; Połom K; Urbaniak B; Sobiech M; Grześkowiak E; Grabowski T; Wolc A; Kokot ZJ; Murawa P
    Pharmacol Rep; 2011; 63(6):1518-25. PubMed ID: 22358099
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pharmacokinetics of controlled-release oxycodone in patients with cancer pain].
    Nakamura K; Kokubun H; Komatsu T; Matoba M; Hoka S; Yago K
    Gan To Kagaku Ryoho; 2007 Sep; 34(9):1449-53. PubMed ID: 17876144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetic-pharmacodynamic relationships of controlled-release oxycodone.
    Kaiko RF; Benziger DP; Fitzmartin RD; Burke BE; Reder RF; Goldenheim PD
    Clin Pharmacol Ther; 1996 Jan; 59(1):52-61. PubMed ID: 8549034
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oxycodone/naloxone preparation can cause acute withdrawal symptoms when misused parenterally or taken orally.
    Wong A; Macleod D; Robinson J; Koutsogiannis Z; Graudins A; Greene SL
    Clin Toxicol (Phila); 2015; 53(8):815-8. PubMed ID: 26109423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of itraconazole on the pharmacokinetics and pharmacodynamics of intravenously and orally administered oxycodone.
    Saari TI; Grönlund J; Hagelberg NM; Neuvonen M; Laine K; Neuvonen PJ; Olkkola KT
    Eur J Clin Pharmacol; 2010 Apr; 66(4):387-97. PubMed ID: 20076952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of physical manipulation on in vitro and in vivo release profiles of oxycodone DETERx®: an extended-release, abuse-deterrent formulation.
    Kopecky EA; Fleming AB; Noonan PK; Varanasi RK; Grima M; Saim S; Mayock SP
    J Opioid Manag; 2014; 10(4):233-46. PubMed ID: 25162603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Should the dosage of controlled-release oxycodone in advanced cancer be modified on the basis of patient characteristics?
    Charles B; Hardy J; Anderson H; Tapuni A; George R; Norris R
    Support Care Cancer; 2014 Feb; 22(2):325-30. PubMed ID: 24077699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.